Your browser doesn't support javascript.
loading
The Role of Transcription Factor PPAR-γ in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells.
Sobolev, Vladimir V; Tchepourina, Ekaterina; Korsunskaya, Irina M; Geppe, Natalia A; Chebysheva, Svetlana N; Soboleva, Anna G; Mezentsev, Alexandre.
Afiliação
  • Sobolev VV; Center for Theoretical Problems in Physico-Chemical Pharmacology, Russian Academy of Sciences, Moscow 109029, Russia.
  • Tchepourina E; Center for Theoretical Problems in Physico-Chemical Pharmacology, Russian Academy of Sciences, Moscow 109029, Russia.
  • Korsunskaya IM; Center for Theoretical Problems in Physico-Chemical Pharmacology, Russian Academy of Sciences, Moscow 109029, Russia.
  • Geppe NA; NF Filatov Clinical Institute of Children's Health at I.M. Sechenov First MSMU, Moscow 119435, Russia.
  • Chebysheva SN; NF Filatov Clinical Institute of Children's Health at I.M. Sechenov First MSMU, Moscow 119435, Russia.
  • Soboleva AG; Center for Theoretical Problems in Physico-Chemical Pharmacology, Russian Academy of Sciences, Moscow 109029, Russia.
  • Mezentsev A; Scientific Research Institute of Human Morphology, 3 Tsurupa Street, Moscow 117418, Russia.
Int J Mol Sci ; 23(17)2022 Aug 26.
Article em En | MEDLINE | ID: mdl-36077103
ABSTRACT
The peroxisome proliferator-activated receptor PPAR-γ is one of three PPAR nuclear receptors that act as ligand-activated transcription factors. In immune cells, the skin, and other organs, PPAR-γ regulates lipid, glucose, and amino acid metabolism. The receptor translates nutritional, pharmacological, and metabolic stimuli into the changes in gene expression. The activation of PPAR-γ promotes cell differentiation, reduces the proliferation rate, and modulates the immune response. In the skin, PPARs also contribute to the functioning of the skin barrier. Since we know that the route from identification to the registration of drugs is long and expensive, PPAR-γ agonists already approved for other diseases may also represent a high interest for psoriasis. In this review, we discuss the role of PPAR-γ in the activation, differentiation, and proliferation of skin and immune cells affected by psoriasis and in contributing to the pathogenesis of the disease. We also evaluate whether the agonists of PPAR-γ may become one of the therapeutic options to suppress the inflammatory response in lesional psoriatic skin and decrease the influence of comorbidities associated with psoriasis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / PPAR gama Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / PPAR gama Idioma: En Ano de publicação: 2022 Tipo de documento: Article